Search Blog
February 2014
« Jan   Mar »


Advaxis, Inc. – “Georgia Regents Trials”


By Market Exclusive

Advaxis Inc. (NASDAQ:ADXS) today
published a new blog post on The Chairman’s Blog, written by the
company’s COO, Mr. Gregory T. Mayes. is an
exclusive online media publication that provides key executive
officers and key opinion leaders a unique platform to share insights
about company and industry trends.

Mr. Mayes blogs about the company’s
recently announced collaboration with GRU Cancer Center at Georgia
Regents University. In it, he speaks about how Advaxis plans on
expanding its existing relationship with GRU Cancer Center and Dr.
Khleif to harness “the power and strength of the caner
immunotherapy research at GRU.”  Read the full blog post on

About Advaxis, Inc.

Advaxis is a
clinical-stage biotechnology company developing the next generation
of cancer immunotherapies. Advaxis immunotherapies are based on a
novel platform technology using live, attenuated bacteria that are
bio-engineered to secrete an antigen/adjuvant fusion protein(s) that
is designed to redirect the powerful immune response all human beings
have to the bacterium to the cancer itself.

ADXS-HPV is currently being evaluated
in Phase 1 and 2 clinical trials for HPV-associated cancers:
recurrent cervical cancer (completed Phase 2 study conducted in
India), locally advanced cervical cancer (GOG/NCI U.S. study,
Clinical Identifier NCT01266460), head & neck cancer
(CRUK study, Clinical Identifier NCT01598792, Mt. Sinai
study, Clinical Identifier NCT02002182), and anal cancer
(BrUOG U.S. study, Clinical Identifier NCT01671488).
Advaxis has over 15 distinct immunotherapies in various stages of
development, developed directly by Advaxis and through strategic
collaborations with recognized centers of excellence such as: the
University of Pennsylvania, the Georgia Regents University Cancer
Center, Icahn School of Medicine at Mount Sinai, and others.

For more information please visit:

About is an exclusive,
online media publication where publically and privatively held firms
alike share insights about their companies and industries. enables upper tier management to discuss issues
that are of importance to their stakeholders, shareholders, and
interested parties in an informal environment. In addition to
management`s insightful blog posts, staff and
aggregate partners contribute articles on finance, technology,
health, and energy while providing updated market trends, news, and